Background-Pneumocystis canimi pneumonia was thought to occur from reactivation of latent infection, but recent studies with the polymerase chain reaction have failed to detect P carinii in normal subjects. If pneumocystis pneumonia is therefore caused by new infection the source and mode of transmission of P carinii remaIs unknown. Methods-Natural exposure to P carinii was detected by measuring antibodies by indirect immunofluorescence in 24 health care workers working continuously with patients with AIDS and 24 control health care workers exclusively treating elderly patients.
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Results-P carrnii antibody titres were significantly higher in the health care workers exposed to AIDS than in the control group (median titre 1:32 v 1:16 respectively). Three control subjects had no antibodies compared with none of the subjects exposed to AIDS, and 10 of the 12 highest titres came from the exposed group. Conclusions Apart from two homosexuals in the exposed group who were negative for HIV in serial tests, all subjects were at low risk of HIV infection. Specimens of serum were taken from all subjects and saved at -80°C for antibody testing.
DETECTION OF ANTIBODIES
All specimens were randomised and coded to ensure blind testing for antibodies. P carinii antibodies were detected by indirect immunofluorescence using sections of human postmortem lung which were heavily infected with P cainii. These sections had been fixed in Bouin's fluid to destroy existing immunoglobulin and preserve the pneumo-cystis polysaccharide antigen. Sections were deparaffinised, rehydrated, and washed for 30 minutes in phosphate buffered saline at pH 7-4. The slides were then reacted for 30 minutes with a sample of each subject's serum diluted 1:8 with phosphate buffered saline. After washing, the slides were treated for 30 minutes with a 1:32 dilution of sheep derived fluorescein labelled whole antihuman immunoglobulin (Murex Diagnostics, Dartford). After washing, slides were mounted under phosphate buffered saline/glycerol (Citifluor, Citifluor Ltd, London) to preserve fluorescence, and viewed at 50 x magnification under oil immersion and ultra violet light. Positive and negative control serum samples were included to confirm adequate staining, and all slides were viewed independently by two observers. Positive specimens, identified by clumps of fluorescing pneumocysts, were tested further at increasing, doubling, serum dilutions-that is, 1:16, 1:32, etc-until a negative result was obtained, and specimens giving different results between the two observers were repeated. Specimens with titres of 1:128 or more were also tested for IgM specific P carinii antibody with the same method but substituting IgM specific antihuman antibody for the whole antihuman immunoglobulin (Murex Diagnostic, Dartford). Results for the two groups were analysed, after breaking the code, with the Mann-Whitney test.
Results
There was good overall agreement between the two observers, with a concordance rate of 90%. A high background fluorescence, the most frequent cause of discrepancies, was invariably resolved after restaining.
Overall, 45 of the 48 specimens (94%) had negative for antibody all came from the control group, whereas the four samples with titres of 1:128 and above (which were also tested for P carinii IgM) came from the group exposed to AIDS. Antibody titres in the exposed group were significantly higher than in the control group, with a median titre of 1:32 (range 1:16 to 1:256) v 1:16 (0 to 1:64), respectively (p < 0-001). IgM was not detectable in samples from the two subjects with total antibody titres of 1:128, and IgM titres of 1:8 and 1:64 were found in the samples from the other two subjects with total antibody titres of 1:256 (table) . Neither of these latter two subjects had recently had respiratory illness and both remained symptom free. One (case 1) was a nurse responsible for helping with inpatient bronchoscopies to investigate patients with suspected pneumocystis pneumonia, and the other (case 2) was a research nurse who had been working with patients with AIDS for seven years. We found no relation between antibody titre and length of time working with patients infected with HIV or between the antibody titres in medical and nursing staff.
Discussion
The finding of an overall high prevalence of P carinii antibodies agrees with most other seroprevalence studies. The wide variation in the prevalence detected in these studies, rang- ing to serial HIV tests, our selection criteria patIents kept this possibility to a minimum. Differences in the age and sex distribution of the two groups were small and probably did not skew the difference in antibody titres between the two groups. Another possible source of error was the two homosexuals in the exposed group, who may have been exposed to P carinii socially rather than professionally. Both their antibody titres, however, were below the group average at 1: 16, and they had no haematological evidence of immune paresis.
The presence of significant IgM titres in association with the highest total antibody titres may indicate that these individuals had been recently exposed to P carinii, although both subjects remained free of respiratory symptoms. The high antibody titres of the bronchoscopy nurse are noteworthy because she was probably being regularly exposed to fluid aerosols containing P carinii. Although we cannot eliminate other, unidentified, sources of P carinii as the cause of raised antibody titres, these findings suggest that patients with AIDS may be a potentially infectious source of P carinii to susceptible individuals. As different serotypes of human P carinii can now be distinguished by molecular biological techniques, some of the questions about the epidemiology and transmission of P carinii infection may soon be resolved.
In conclusion, this study adds to the growing evidence that infection with P carinii may be transmitted from infected carriers, who may be a potential source of pneumocystis pneumonia in immunosuppressed subjects. 
